Ekso Bionics Holdings Interest Expense 2011-2026 | EKSO

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Ekso Bionics Holdings

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-1 K	-63 K	156 K	113 K	139 K	384 K	600 K	648 K	16 K	13 K	435 K	1.73 M	736 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.73 M	-63 K	377 K

Quarterly Interest Expense Ekso Bionics Holdings

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-8 K	-6 K	-	-2 K	-	57 K	-	3 K	-30 K	112 K	-	34 K	29 K	27 K	-	24 K	27 K	26 K	-	23 K	38 K	52 K	-	88 K	107 K	121 K	-	145 K	160 K	163 K	-	165 K	198 K	119 K	-	-1.61 M	1.63 M	2.99 M	-	4 K	3 K	3 K	-	3 K	3 K	427 K	-	170 K	674 K	639 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.99 M	-1.61 M	179 K

Interest Expense of other stocks in the Medical instruments industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	149	-	-	$ 810 M	USA
Baxter International BAX	408 M	$ 20.22	-0.74 %	$ 10.3 B	USA
Haemonetics Corporation HAE	-9.75 M	$ 72.55	-1.96 %	$ 3.65 B	USA
ICU Medical ICUI	107 M	$ 156.76	1.06 %	$ 3.82 B	USA
Repro Med Systems KRMD	561 K	$ 5.57	-1.76 %	$ 254 M	USA
Alcon ALC	192 M	$ 79.29	-0.48 %	$ 40.4 B	Schweiz
LeMaitre Vascular LMAT	205 K	$ 87.95	1.68 %	$ 1.97 B	USA
AtriCure ATRC	-326 K	$ 39.46	-4.84 %	$ 1.85 B	USA
electroCore ECOR	6.3 M	$ 7.17	5.65 %	$ 39.5 K	USA
Masimo Corporation MASI	300 K	$ 141.12	0.89 %	$ 7.52 B	USA
AngioDynamics ANGO	4.94 M	$ 10.43	-5.27 %	$ 426 M	USA
The Cooper Companies COO	-16.4 M	$ 82.65	0.41 %	$ 16.5 B	USA
Harvard Bioscience HBIO	-227 K	$ 0.59	1.28 %	$ 25 M	USA
Glaukos Corporation GKOS	13.6 M	$ 120.04	4.86 %	$ 5.81 B	USA
InfuSystem Holdings INFU	1.4 M	$ 8.81	2.44 %	$ 182 M	USA
Isoray ISR	2 K	-	0.03 %	$ 108 M	USA
OraSure Technologies OSUR	-380 K	$ 2.7	-1.64 %	$ 201 M	USA
iRhythm Technologies IRTC	1.25 M	$ 167.42	-2.69 %	$ 5.22 B	USA
Predictive Oncology POAI	3	$ 6.15	-13.12 %	$ 33.5 M	USA
Merit Medical Systems MMSI	-711 K	$ 82.27	2.39 %	$ 4.79 B	USA
STERIS plc STE	8.4 M	$ 268.44	0.07 %	$ 26.5 B	USA
Microbot Medical MBOT	2 K	$ 2.17	4.07 %	$ 22.1 M	Israel
Nephros NEPH	2 K	$ 4.35	-0.8 %	$ 45.2 M	USA
Milestone Scientific MLSS	60.3 K	$ 0.29	-0.82 %	$ 23.1 M	USA
Utah Medical Products UTMD	256 K	$ 61.25	1.63 %	$ 222 M	USA
Envista Holdings Corporation NVST	-100 K	$ 25.27	2.35 %	$ 4.35 B	USA
Pro-Dex PDEX	533 K	$ 42.3	1.37 %	$ 139 M	USA
Pulse Biosciences PLSE	983 K	$ 14.29	1.31 %	$ 686 M	USA
Becton, Dickinson and Company BDX	613 M	$ 207.62	-0.35 %	$ 59.7 B	USA
Repligen Corporation RGEN	8.12 M	$ 163.82	1.31 %	$ 9.13 M	USA
ResMed RMD	3.2 M	$ 257.35	-1.29 %	$ 37.6 B	USA
BioLife Solutions BLFS	497 K	$ 24.35	-0.49 %	$ 1.12 B	USA
Stereotaxis STXS	1.1 M	$ 2.72	-2.34 %	$ 220 M	USA
Retractable Technologies RVP	227 K	$ 0.74	3.27 %	$ 22.2 M	USA
STAAR Surgical Company STAA	815 K	$ 20.89	-0.38 %	$ 1.03 B	USA
Teleflex Incorporated TFX	57 M	$ 103.32	-1.23 %	$ 4.84 B	USA
West Pharmaceutical Services WST	-1 M	$ 260.85	-6.64 %	$ 19 B	USA
DENTSPLY SIRONA XRAY	12 M	$ 12.23	-2.78 %	$ 2.49 B	USA